Neoplasms Metastasis Terminated Phase 1 Trials for Temozolomide (DB00853)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00629187Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyTreatment